Stryker to participate in Cowen & Company 37th Annual Health Care Conference
February 21 2017 - 1:16PM
Kalamazoo, Michigan - February 21, 2017 - Stryker
Corporation (NYSE:SYK) will participate in the Cowen & Company
37th Annual Health Care Conference on Monday, March 6, 2017 at the
Boston Marriott Copley Place in Boston, Massachusetts.
Katherine Owen, Vice President, Strategy and Investor
Relations, will represent the Company in a presentation scheduled
for 1:20 p.m. Eastern Time.
A simultaneous webcast and replay of the Company's
presentation will be available on Stryker's website at
www.stryker.com.
Forward-looking
statements
This presentation may contain information that
includes or is based on forward-looking statements within the
meaning of the federal securities law that are subject to various
risks and uncertainties that could cause our actual results to
differ materially from those expressed or implied in such
statements. Such factors include, but are not limited to: weakening
of economic conditions that could adversely affect the level of
demand for our products; pricing pressures generally, including
cost-containment measures that could adversely affect the price of
or demand for our products; changes in foreign exchange markets;
legislative and regulatory actions; unanticipated issues arising in
connection with clinical studies and otherwise that affect U.S.
Food and Drug Administration approval of new products; changes in
reimbursement levels from third-party payors; a significant
increase in product liability claims; the ultimate total cost with
respect to the Rejuvenate and ABG II matter; the impact of
investigative and legal proceedings and compliance risks;
resolution of tax audits; the impact of the federal legislation to
reform the United States healthcare system; changes in financial
markets; changes in the competitive environment; our ability to
integrate acquisitions; and our ability to realize anticipated cost
savings. Additional information concerning these and other factors
is contained in our filings with the U.S. Securities and Exchange
Commission, including our Annual Report on Form 10-K and Quarterly
Reports on Form 10-Q.
Stryker is one of the world's leading medical
technology companies and, together with our customers, we are
driven to make healthcare better. The Company offers a diverse
array of innovative products and services in Orthopaedics,
Medical and Surgical, and Neurotechnology and Spine that help
improve patient and hospital outcomes. Stryker is active in
over 100 countries around the world. Please contact us for
more information at www.stryker.com.
Contacts
For investor inquiries please
contact:
Katherine A. Owen, Stryker Corporation, 269-385-2600 or
katherine.owen@stryker.com
For media inquiries please
contact:
Yin Becker, Stryker Corporation, 269-385-2600 or
yin.becker@stryker.com
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Stryker Corporation via Globenewswire
Stryker (NYSE:SYK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Stryker (NYSE:SYK)
Historical Stock Chart
From Sep 2023 to Sep 2024